136 related articles for article (PubMed ID: 35032593)
1. C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
Klempnauer KH
Exp Hematol; 2022 Apr; 108():8-15. PubMed ID: 35032593
[TBL] [Abstract][Full Text] [Related]
2. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
3. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
Klempnauer KH
Oncotarget; 2023 Mar; 14():174-177. PubMed ID: 36913305
[TBL] [Abstract][Full Text] [Related]
5. Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.
Schmidt TJ; Klempnauer KH
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408476
[TBL] [Abstract][Full Text] [Related]
6. A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
Abdel Ghani L; Yusenko MV; Frank D; Moorthy R; Widen JC; Dörner W; Khandanpour C; Harki DA; Klempnauer KH
Cancer Lett; 2022 Apr; 530():170-180. PubMed ID: 35077804
[TBL] [Abstract][Full Text] [Related]
7. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
Elife; 2021 Feb; 10():. PubMed ID: 33527899
[TBL] [Abstract][Full Text] [Related]
8. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
[TBL] [Abstract][Full Text] [Related]
9. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
[TBL] [Abstract][Full Text] [Related]
10. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
[TBL] [Abstract][Full Text] [Related]
11. Peptidomimetic blockade of MYB in acute myeloid leukemia.
Ramaswamy K; Forbes L; Minuesa G; Gindin T; Brown F; Kharas MG; Krivtsov AV; Armstrong SA; Still E; de Stanchina E; Knoechel B; Koche R; Kentsis A
Nat Commun; 2018 Jan; 9(1):110. PubMed ID: 29317678
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
Yusenko MV; Biyanee A; Andersson MK; Radetzki S; von Kries JP; Stenman G; Klempnauer KH
Cancer Lett; 2021 Nov; 520():132-142. PubMed ID: 34256093
[TBL] [Abstract][Full Text] [Related]
13. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ.
Falkenberg KD; Jakobs A; Matern JC; Dörner W; Uttarkar S; Trentmann A; Steinmann S; Coulibaly A; Schomburg C; Mootz HD; Schmidt TJ; Klempnauer KH
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1349-1358. PubMed ID: 28476645
[TBL] [Abstract][Full Text] [Related]
14. Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.
Clesham K; Walf-Vorderwülbecke V; Gasparoli L; Virely C; Cantilena S; Tsakaneli A; Inglott S; Adams S; Samarasinghe S; Bartram J; Williams G; de Boer J; Williams O
Leukemia; 2022 Jun; 36(6):1541-1549. PubMed ID: 35368048
[TBL] [Abstract][Full Text] [Related]
15. Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity.
Yusenko MV; Biyanee A; Frank D; Köhler LHF; Andersson MK; Khandanpour C; Schobert R; Stenman G; Biersack B; Klempnauer KH
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008207
[TBL] [Abstract][Full Text] [Related]
16. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
[TBL] [Abstract][Full Text] [Related]
17. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.
Yusenko MV; Trentmann A; Andersson MK; Ghani LA; Jakobs A; Arteaga Paz MF; Mikesch JH; Peter von Kries J; Stenman G; Klempnauer KH
Cancer Lett; 2020 Jun; 479():61-70. PubMed ID: 32014461
[TBL] [Abstract][Full Text] [Related]
18. C/EBPbeta induces chromatin opening at a cell-type-specific enhancer.
Plachetka A; Chayka O; Wilczek C; Melnik S; Bonifer C; Klempnauer KH
Mol Cell Biol; 2008 Mar; 28(6):2102-12. PubMed ID: 18195047
[TBL] [Abstract][Full Text] [Related]
19. Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.
Volpe G; Cauchy P; Walton DS; Ward C; Blakemore D; Bayley R; Clarke ML; Schmidt L; Nerlov C; Garcia P; Dumon S; Grebien F; Frampton J
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30877232
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MYB by distal enhancer elements in human myeloid leukemia.
Li M; Jiang P; Cheng K; Zhang Z; Lan S; Li X; Zhao L; Wang Y; Wang X; Chen J; Ji T; Han B; Zhang J
Cell Death Dis; 2021 Feb; 12(2):223. PubMed ID: 33637692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
